Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Promotion of trophoblast invasion by lncRNA MVIH through inducing Jun-B.

Zou Y, Li Q, Xu Y, Yu X, Zuo Q, Huang S, Chu Y, Jiang Z, Sun L.

J Cell Mol Med. 2018 Feb;22(2):1214-1223. doi: 10.1111/jcmm.13400. Epub 2017 Oct 30.

2.

Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.

Limoge M, Safina A, Beattie A, Kapus L, Truskinovsky AM, Bakin AV.

Oncotarget. 2017 May 30;8(22):35592-35608. doi: 10.18632/oncotarget.16022.

3.

Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.

Subramanian D, Bunjobpol W, Sabapathy K.

J Biol Chem. 2015 Jul 24;290(30):18636-49. doi: 10.1074/jbc.M115.636548. Epub 2015 May 27.

4.

JUNB is a key transcriptional modulator of macrophage activation.

Fontana MF, Baccarella A, Pancholi N, Pufall MA, Herbert DR, Kim CC.

J Immunol. 2015 Jan 1;194(1):177-86. doi: 10.4049/jimmunol.1401595. Epub 2014 Dec 3.

5.

A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells.

Liu JJ, Lin XJ, Yang XJ, Zhou L, He S, Zhuang SM, Yang J.

Nucleic Acids Res. 2014 Oct 29;42(19):12041-51. doi: 10.1093/nar/gku872. Epub 2014 Sep 26.

6.

Epithelial sheet movement requires the cooperation of c-Jun and MAP3K1.

Meng Q, Mongan M, Wang J, Tang X, Zhang J, Kao W, Xia Y.

Dev Biol. 2014 Nov 1;395(1):29-37. doi: 10.1016/j.ydbio.2014.09.001. Epub 2014 Sep 16.

7.

A FATal AP-1 dimer switch in hepatosteatosis.

Bakiri L, Hasenfuss SC, Wagner EF.

Cell Cycle. 2014;13(8):1218-9. doi: 10.4161/cc.28514. Epub 2014 Mar 12. No abstract available.

8.

JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Thomsen MK, Bakiri L, Hasenfuss SC, Hamacher R, Martinez L, Wagner EF.

J Clin Invest. 2013 Dec;123(12):5258-68. doi: 10.1172/JCI70405. Epub 2013 Nov 8.

9.

Signal-dependent fra-2 regulation in skeletal muscle reserve and satellite cells.

Alli NS, Yang EC, Miyake T, Aziz A, Collins-Hooper H, Patel K, McDermott JC.

Cell Death Dis. 2013 Jun 27;4:e692. doi: 10.1038/cddis.2013.221.

10.

AP1 transcription factors in epidermal differentiation and skin cancer.

Eckert RL, Adhikary G, Young CA, Jans R, Crish JF, Xu W, Rorke EA.

J Skin Cancer. 2013;2013:537028. doi: 10.1155/2013/537028. Epub 2013 May 23.

11.

Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.

Lee JK, Pearson JD, Maser BE, Ingham RJ.

J Biol Chem. 2013 Jul 26;288(30):21482-95. doi: 10.1074/jbc.M113.485672. Epub 2013 Jun 9.

12.

Jun is required in Isl1-expressing progenitor cells for cardiovascular development.

Zhang T, Liu J, Zhang J, Thekkethottiyil EB, Macatee TL, Ismat FA, Wang F, Stoller JZ.

PLoS One. 2013;8(2):e57032. doi: 10.1371/journal.pone.0057032. Epub 2013 Feb 21.

13.

Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation.

Han B, Rorke EA, Adhikary G, Chew YC, Xu W, Eckert RL.

PLoS One. 2012;7(5):e36941. doi: 10.1371/journal.pone.0036941. Epub 2012 May 23.

14.

Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells.

Stueckle TA, Lu Y, Davis ME, Wang L, Jiang BH, Holaskova I, Schafer R, Barnett JB, Rojanasakul Y.

Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16. doi: 10.1016/j.taap.2012.04.003. Epub 2012 Apr 13.

15.

JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β.

Gervasi M, Bianchi-Smiraglia A, Cummings M, Zheng Q, Wang D, Liu S, Bakin AV.

J Cell Biol. 2012 Mar 5;196(5):589-603. doi: 10.1083/jcb.201109045.

16.

c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Jin JY, Ke H, Hall RP, Zhang JY.

J Invest Dermatol. 2011 May;131(5):1149-58. doi: 10.1038/jid.2011.1. Epub 2011 Feb 3. Erratum in: J Invest Dermatol. 2011 Jun;131(6):1388.

17.

AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation.

Rorke EA, Adhikary G, Jans R, Crish JF, Eckert RL.

Oncogene. 2010 Nov 4;29(44):5873-82. doi: 10.1038/onc.2010.315. Epub 2010 Sep 6.

18.

Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric-oxide synthase expression in placental artery endothelial cells.

Mata-Greenwood E, Liao WX, Wang W, Zheng J, Chen DB.

J Biol Chem. 2010 Jun 4;285(23):17348-58. doi: 10.1074/jbc.M109.092791. Epub 2010 Apr 6.

19.

Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Lopez-Bergami P, Lau E, Ronai Z.

Nat Rev Cancer. 2010 Jan;10(1):65-76. doi: 10.1038/nrc2681. Review. Erratum in: Nat Rev Cancer. 2010 May;10(5):379.

20.

Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection.

Hussain S, Bharti AC, Salam I, Bhat MA, Mir MM, Hedau S, Siddiqi MA, Basir SF, Das BC.

BMC Cancer. 2009 Sep 16;9:329. doi: 10.1186/1471-2407-9-329.

Supplemental Content

Support Center